{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T01:55:18Z","timestamp":1770515718832,"version":"3.49.0"},"reference-count":82,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100001655","name":"Deutscher Akademischer Austauschdienst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2017.00037","type":"journal-article","created":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T03:54:35Z","timestamp":1489550075000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["From Toxoplasmosis to Schizophrenia via NMDA Dysfunction: Peptide Overlap between Toxoplasma gondii and N-Methyl-d-Aspartate Receptors As a Potential Mechanistic Link"],"prefix":"10.3389","volume":"8","author":[{"given":"Guglielmo","family":"Lucchese","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2017,3,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0140-6736(15)01121-6","article-title":"Schizophrenia","volume":"388","author":"Owen","year":"2016","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.tins.2008.02.005","article-title":"Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia","volume":"31","author":"Lisman","year":"2008","journal-title":"Trends Neurosci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/j.1365-3024.2009.01131.x","article-title":"Toxoplasma and schizophrenia","volume":"31","author":"Yolken","year":"2009","journal-title":"Parasite Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1093\/schbul\/sbv134","article-title":"Shared immune and repair markers during experimental Toxoplasma chronic brain infection and schizophrenia","volume":"42","author":"Tomasik","year":"2016","journal-title":"Schizophr Bull"},{"key":"B5","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/schbul\/sbm005","article-title":"Toxoplasma gondii in individuals with schizophrenia: association with clinical and demographic factors and with mortality","volume":"33","author":"Dickerson","year":"2007","journal-title":"Schizophr Bull"},{"key":"B6","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/schbul\/sbm009","article-title":"Early infections of Toxoplasma gondii and the later development of schizophrenia","volume":"33","author":"Mortensen","year":"2007","journal-title":"Schizophr Bull"},{"key":"B7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1600-0447.2006.00780.x","article-title":"Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia","volume":"114","author":"Wang","year":"2006","journal-title":"Acta Psychiatr Scand"},{"key":"B8","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1093\/schbul\/sbl050","article-title":"Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis","volume":"33","author":"Torrey","year":"2007","journal-title":"Schizophr Bull"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e978","DOI":"10.1016\/j.ijid.2010.05.018","article-title":"Toxoplasma gondii infection in first-episode and inpatient individuals with schizophrenia","volume":"14","author":"Hamidinejat","year":"2010","journal-title":"Int J Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/acps.12423","article-title":"Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis","volume":"132","author":"Sutterland","year":"2015","journal-title":"Acta Psychiatr Scand"},{"key":"B11","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/schbul\/sbs043","article-title":"Toxoplasma gondii and other risk factors for schizophrenia: an update","volume":"38","author":"Torrey","year":"2012","journal-title":"Schizophr Bull"},{"key":"B12","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1093\/schbul\/sbu159","article-title":"Meta-analysis of anti-Toxoplasma gondii IgM antibodies in acute psychosis","volume":"41","author":"Monroe","year":"2015","journal-title":"Schizophr Bull"},{"key":"B13","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1176\/appi.ajp.162.4.767","article-title":"Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring","volume":"162","author":"Brown","year":"2005","journal-title":"Am J Psychiatry"},{"key":"B14","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.biopsych.2006.05.024","article-title":"Toxoplasma gondii as a risk factor for schizophrenia: analysis of filter paper blood samples obtained at birth","volume":"61","author":"Mortensen","year":"2007","journal-title":"Biol Psychiatry"},{"key":"B15","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0022-3956(99)00029-1","article-title":"NMDA receptor hypofunction model of schizophrenia","volume":"33","author":"Olney","year":"1999","journal-title":"J Psychiatr Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0074-7742(06)78003-5","article-title":"Glutamate and schizophrenia: phencyclidine, N-methyl-d-aspartate receptors, and dopamine-glutamate interactions","volume":"78","author":"Javitt","year":"2007","journal-title":"Int Rev Neurobiol"},{"key":"B17","first-page":"4","article-title":"Glutamatergic theories of schizophrenia","volume":"47","author":"Javitt","year":"2010","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"B18","first-page":"12","article-title":"Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia","volume":"9","author":"Javitt","year":"1987","journal-title":"Hillside J Clin Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am J Psychiatry"},{"key":"B20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1097\/00001756-199504190-00011","article-title":"Ketamine activates psychosis and alters limbic blood flow in schizophrenia","volume":"6","author":"Lahti","year":"1995","journal-title":"Neuroreport"},{"key":"B22","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.brainresbull.2010.04.006","article-title":"N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?","volume":"83","author":"Kantrowitz","year":"2010","journal-title":"Brain Res Bull"},{"key":"B23","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/schbul\/sbs076","article-title":"NMDA receptor and schizophrenia: a brief history","volume":"38","author":"Coyle","year":"2012","journal-title":"Schizophr Bull"},{"key":"B24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.biopsych.2014.07.011","article-title":"Genetic risk for schizophrenia: convergence on synaptic pathways involved in plasticity","volume":"77","author":"Hall","year":"2015","journal-title":"Biol Psychiatry"},{"key":"B25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1055\/s-0034-1383657","article-title":"The glutamate hypothesis: a pathogenic pathway from which pharmacological interventions have emerged","volume":"47","author":"Veerman","year":"2014","journal-title":"Pharmacopsychiatry"},{"key":"B26","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/0269881114563634","article-title":"Glutamate and dopamine in schizophrenia: an update for the 21st century","volume":"29","author":"Howes","year":"2015","journal-title":"J Psychopharmacol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fncel.2013.00031","article-title":"NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia","volume":"7","author":"Snyder","year":"2013","journal-title":"Front Cell Neurosci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1046\/j.1460-9568.2003.02902.x","article-title":"Long-term behavioural, molecular and morphological effects of neonatal NMDA receptor antagonism","volume":"18","author":"Harris","year":"2003","journal-title":"Eur J Neurosci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1177\/0269881113512909","article-title":"Reviewing the Ketamine Model for schizophrenia","volume":"28","author":"Frohlich","year":"2014","journal-title":"J Psychopharmacol"},{"key":"B30","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1096\/fasebj.12.13.1255","article-title":"Molecular mimicry and immune-mediated diseases","volume":"12","author":"Oldstone","year":"1998","journal-title":"FASEB J"},{"key":"B31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0966-842X(03)00006-4","article-title":"Mimicking the way to autoimmunity: an evolving theory of sequence and structural homology","volume":"11","author":"Kohm","year":"2003","journal-title":"Trends Microbiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.schres.2014.05.001","article-title":"Meta-analysis of the association between N-methyl-d-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder","volume":"157","author":"Pearlman","year":"2014","journal-title":"Schizophr Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1471-244X-12-37","article-title":"Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features","volume":"12","author":"Tsutsui","year":"2012","journal-title":"BMC Psychiatry"},{"key":"B34","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s00415-010-5788-9","article-title":"Disease-relevant autoantibodies in first episode schizophrenia","volume":"258","author":"Zandi","year":"2011","journal-title":"J Neurol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1001\/2013.jamapsychiatry.86","article-title":"Increased prevalence of diverse N-methyl-d-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-d-aspartate glutamate receptor encephalitis","volume":"70","author":"Steiner","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"B36","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/j.1399-5618.2012.01028.x","article-title":"Antibodies to the glutamate receptor in mania","volume":"14","author":"Dickerson","year":"2012","journal-title":"Bipolar Disord"},{"key":"B37","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.biopsych.2013.07.018","article-title":"Antibodies to the N-methyl-d-aspartate receptor and other synaptic proteins in psychosis","volume":"75","author":"Deakin","year":"2014","journal-title":"Biol Psychiatry"},{"key":"B38","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.nbd.2016.03.005","article-title":"Anti-NMDA receptor autoantibodies and associated neurobehavioral pathology in mice are dependent on age of first exposure to Toxoplasma gondii","volume":"91","author":"Kannan","year":"2016","journal-title":"Neurobiol Dis"},{"key":"B39","doi-asserted-by":"publisher","first-page":"D169","DOI":"10.1093\/nar\/gkn664","article-title":"The universal protein resource (UniProt) 2009","volume":"37","author":"UniProt Consortium","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1093\/bioinformatics\/btt484","article-title":"A fast Peptide Match service for UniProt knowledgebase","volume":"29","author":"Chen","year":"2013","journal-title":"Bioinformatics"},{"key":"B41","doi-asserted-by":"publisher","first-page":"D854","DOI":"10.1093\/nar\/gkp1004","article-title":"The immune epitope database 2.0","volume":"38","author":"Vita","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"B42","doi-asserted-by":"crossref","DOI":"10.1515\/9780691220161","volume-title":"Immunology and Evolution of Infectious Disease","author":"Frank","year":"2002"},{"key":"B43","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.1016\/j.molimm.2007.04.004","article-title":"The C-terminal pentapeptide of LHRH is a dominant B cell epitope with antigenic and biological function","volume":"44","author":"Zeng","year":"2007","journal-title":"Mol Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2174\/1389203711314020003","article-title":"Pentapeptides as minimal functional units in cell biology and immunology","volume":"14","author":"Kanduc","year":"2013","journal-title":"Curr Protein Pept Sci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.mib.2015.07.009","article-title":"Taking a bite: amoebic trogocytosis in Entamoeba histolytica and beyond","volume":"28","author":"Ralston","year":"2015","journal-title":"Curr Opin Microbiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrn3504","article-title":"NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease","volume":"14","author":"Paoletti","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1097\/00001756-199212000-00027","article-title":"Developmental changes in distribution of NMDA receptor channel subunit mRNAs","volume":"3","author":"Watanabe","year":"1992","journal-title":"Neuroreport"},{"key":"B48","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/0896-6273(94)90210-0","article-title":"Developmental and regional expression in the rat brain and functional properties of four NMDA receptors","volume":"12","author":"Monyer","year":"1994","journal-title":"Neuron"},{"key":"B49","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0169-328X(96)00117-9","article-title":"Expression of NMDAR2D glutamate receptor subunit mRNA in neurochemically identified interneurons in the rat neostriatum, neocortex and hippocampus","volume":"42","author":"Standaert","year":"1996","journal-title":"Brain Res Mol Brain Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0169-328X(02)00183-3","article-title":"Immunohistochemical localization of N-methyl-d-aspartate receptor subunits in the adult murine hippocampal formation: evidence for a unique role of the NR2D subunit","volume":"102","author":"Thompson","year":"2002","journal-title":"Brain Res Mol Brain Res"},{"key":"B51","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3389\/fncel.2015.00095","article-title":"GluN2D-containing NMDA receptors-mediate synaptic currents in hippocampal interneurons and pyramidal cells in juvenile mice","volume":"9","author":"von Engelhardt","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"B52","first-page":"1","article-title":"NMDA receptors and brain development","volume-title":"Biology of the NMDA Receptor","author":"Ewald","year":"2009"},{"key":"B53","doi-asserted-by":"publisher","first-page":"145387","DOI":"10.1155\/2013\/145387","article-title":"GluN3A: an NMDA receptor subunit with exquisite properties and functions","volume":"2013","author":"Kehoe","year":"2013","journal-title":"Neural Plast"},{"key":"B54","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1523\/JNEUROSCI.14-05-03180.1994","article-title":"Regional and developmental heterogeneity in splicing of the rat brain NMDAR1 mRNA","volume":"14","author":"Laurie","year":"1994","journal-title":"J Neurosci"},{"key":"B55","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.schres.2014.09.041","article-title":"GABAergic mechanisms of hippocampal hyperactivity in schizophrenia","volume":"167","author":"Heckers","year":"2015","journal-title":"Schizophr Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00401-011-0881-4","article-title":"Bipolar disorder type 1 and schizophrenia are accompanied by decreased density of parvalbumin- and somatostatin-positive interneurons in the parahippocampal region","volume":"122","author":"Wang","year":"2011","journal-title":"Acta Neuropathol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.schres.2011.06.007","article-title":"Hippocampal interneurons are abnormal in schizophrenia","volume":"131","author":"Konradi","year":"2011","journal-title":"Schizophr Res"},{"key":"B58","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/bph.12518","article-title":"GluN2C\/GluN2D subunit-selective NMDA receptor potentiator CIQ reverses MK-801-induced impairment in prepulse inhibition and working memory in Y-maze test in mice","volume":"171","author":"Suryavanshi","year":"2014","journal-title":"Br J Pharmacol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1124\/jpet.115.230391","article-title":"GluN2D N-methyl-d-aspartate receptor subunit contribution to the stimulation of brain activity and gamma oscillations by ketamine: implications for schizophrenia","volume":"356","author":"Sapkota","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"B60","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neulet.2015.10.049","article-title":"Role of the NMDA receptor GluN2D subunit in the expression of ketamine-induced behavioral sensitization and region-specific activation of neuronal nitric oxide synthase","volume":"610","author":"Yamamoto","year":"2016","journal-title":"Neurosci Lett"},{"key":"B61","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1756-6606-6-56","article-title":"Involvement of the N-methyl-d-aspartate receptor GluN2D subunit in phencyclidine-induced motor impairment, gene expression, and increased Fos immunoreactivity","volume":"6","author":"Yamamoto","year":"2013","journal-title":"Mol Brain"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e13722","DOI":"10.1371\/journal.pone.0013722","article-title":"Essential role of NMDA receptor channel \u03b54 subunit (GluN2D) in the effects of phencyclidine, but not methamphetamine","volume":"5","author":"Hagino","year":"2010","journal-title":"PLoS One"},{"key":"B63","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0304-3940(93)90341-H","article-title":"Basket-like interneurones in layer II of the entorhinal cortex exhibit a powerful NMDA-mediated synaptic excitation","volume":"149","author":"Jones","year":"1993","journal-title":"Neurosci Lett"},{"key":"B64","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.schres.2014.12.026","article-title":"The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia","volume":"167","author":"Cohen","year":"2015","journal-title":"Schizophr Res"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1152\/physrev.00035.2008","article-title":"Neurophysiological and computational principles of cortical rhythms in cognition","volume":"90","author":"Wang","year":"2010","journal-title":"Physiol Rev"},{"key":"B66","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev-neuro-062111-150444","article-title":"Mechanisms of gamma oscillations","volume":"35","author":"Buzs\u00e1ki","year":"2012","journal-title":"Annu Rev Neurosci"},{"key":"B67","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.biopsych.2015.07.005","article-title":"Abnormal gamma oscillations in N-methyl-d-aspartate receptor hypofunction models of schizophrenia","volume":"79","author":"Jadi","year":"2016","journal-title":"Biol Psychiatry"},{"key":"B68","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1093\/schbul\/sbs010","article-title":"NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia","volume":"38","author":"Gonzalez-Burgos","year":"2012","journal-title":"Schizophr Bull"},{"key":"B69","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/YCO.0000000000000244","article-title":"Gamma band oscillations: a key to understanding schizophrenia symptoms and neural circuit abnormalities","volume":"29","author":"McNally","year":"2016","journal-title":"Curr Opin Psychiatry"},{"key":"B70","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1093\/schbul\/sbm062","article-title":"Neural synchrony in schizophrenia: from networks to new treatments","volume":"33","author":"Ford","year":"2007","journal-title":"Schizophr Bull"},{"key":"B71","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.tics.2003.10.012","article-title":"Synchronous neural oscillations and cognitive processes","volume":"7","author":"Ward","year":"2003","journal-title":"Trends Cogn Sci"},{"key":"B72","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1146\/annurev.neuro.051508.135603","article-title":"Neuronal gamma-band synchronisation as a fundamental process in cortical computation","volume":"32","author":"Fries","year":"2009","journal-title":"Annu Rev Neurosci"},{"key":"B73","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0301-0082(97)00023-3","article-title":"High-frequency brain activity: its possible role in attention, perception and language processing","volume":"52","author":"Pulverm\u00fcller","year":"1997","journal-title":"Prog Neurobiol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3389\/fncom.2016.00145","article-title":"A spiking neurocomputational model of high-frequency oscillatory brain responses to words and pseudowords","volume":"10","author":"Garagnani","year":"2017","journal-title":"Front Comput Neurosci"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.neuropharm.2011.02.007","article-title":"Gamma synchrony: towards a translational biomarker for the treatment resistant symptoms of schizophrenia","volume":"62","author":"Gandal","year":"2012","journal-title":"Neuropharmacology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nrn2774","article-title":"Abnormal neural oscillations and synchrony in schizophrenia","volume":"11","author":"Uhlhaas","year":"2010","journal-title":"Nat Rev Neurosci"},{"issue":"8","key":"B77","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1001\/jamapsychiatry.2014.2642","article-title":"Spontaneous gamma activity in schizophrenia","volume":"72","author":"Hirano","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"B78","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3389\/fpsyg.2015.00478","article-title":"Schizophrenia: from neurophysiological abnormalities to clinical symptoms","volume":"6","author":"Castelnovo","year":"2015","journal-title":"Front Psychol"},{"issue":"1","key":"B79","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.tins.2011.10.004","article-title":"Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia","volume":"35","author":"Lewis","year":"2012","journal-title":"Trends Neurosci"},{"key":"B80","doi-asserted-by":"publisher","first-page":"716","DOI":"10.2741\/4133","article-title":"Confronting JC virus and Homo sapiens biological signatures","volume":"18","author":"Lucchese","year":"2013","journal-title":"Front Biosci"},{"key":"B81","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/schbul\/sbs197","article-title":"Peptide sharing between influenza A H1N1 hemagglutinin and human axon guidance proteins","volume":"40","author":"Lucchese","year":"2014","journal-title":"Schizophr Bull"},{"key":"B82","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fpsyt.2016.00060","article-title":"Understanding neuropsychiatric diseases, analysing the peptide sharing between infectious agents and the language-associated NMDA 2A protein","volume":"7","author":"Lucchese","year":"2016","journal-title":"Front Psychiatry"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fpsyt.2017.00037\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T05:37:27Z","timestamp":1658813847000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fpsyt.2017.00037\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,15]]},"references-count":82,"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2017.00037","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,15]]}}}